Prime Medicine, Inc. P/FCF ratio

P/FCF ratio of PRME for past 10 years: annual, quarterly and twelve month trailing (TTM) including P/FCF ratio growth rates and interactive chart. A valuation metric that measures the share price of a stock compared to its free cash flow per share. Free cash flow is calculated as operating cash flow - capital expenditures and is a more accurate measure of a company's earning power than net income, as it's not easily manipulated. A low P/FCF ratio can indicate undervaluation, while a high one might mean the growth expectations around the company are elevated. P/FCF ratio can be compared to different companies in the same industry or to a company’s own historical valuation.

Highlights and Quick Summary

Current P/FCF ratio of Prime Medicine, Inc. is 0.0 (as of December 31, 2020)
  • Annual P/FCF ratio for 2020 was 0.0
Visit stockrow.com/PRME for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical P/FCF ratio of Prime Medicine, Inc.

Most recent P/FCF ratioof PRME including historical data for past 10 years.

Interactive Chart of P/FCF ratio of Prime Medicine, Inc.

Prime Medicine, Inc. P/FCF ratio for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 – – – – 0.0

Business Profile of Prime Medicine, Inc.

Sector: Healthcare
Industry: Biotechnology
© stockrow.com